These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 8930462)

  • 21. Effect on sensitisation of giving HLA-DR-matched blood to potential renal transplant recipients.
    Middleton D; Martin J; Magee BA; Douglas JF
    Transplant Proc; 1992 Dec; 24(6):2535-6. PubMed ID: 1465857
    [No Abstract]   [Full Text] [Related]  

  • 22. HLA-DR matching and anti-donor-specific antibodies in kidney transplant recipients.
    Valeri M; Piazza A; Torlone N; Poggi E; Monaco PI; Provenzani L; Adorno D; Casciani CU
    Transplant Proc; 1992 Dec; 24(6):2514-6. PubMed ID: 1465850
    [No Abstract]   [Full Text] [Related]  

  • 23. Significance of anti-HLA and donor-specific antibodies in long-term renal graft survival.
    Saidman S
    Transplant Proc; 2007 Apr; 39(3):744-6. PubMed ID: 17445587
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The polymorphic human TLX-B/CD46/MCP system and its implications in transplantation and reproduction.
    Petrányi G; Padányi A; Szelényi J; Sármay G; Gyódi E; Fülöp V; Kassai M; Illés P; Réti M; Szigetvári I
    Eur J Immunogenet; 1995 Apr; 22(2):147-61. PubMed ID: 7605772
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X; Ishida H; Yamaguchi Y; Tanabe K
    Transpl Int; 2008 Dec; 21(12):1145-52. PubMed ID: 18803618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Soluble HLA and anti-idiotypic antibodies in transplantation: modulation of anti-HLA antibodies by soluble HLA antigens from the graft and anti-idiotypic antibodies in renal and cardiac allograft recipients.
    Suciu-Foca N; Ho E; King DW; Yu YP; Yu-Kai S; Reed E; Cohen D; Brensilver JM; McCabe R; Rose E
    Transplant Proc; 1991 Feb; 23(1 Pt 1):295-6. PubMed ID: 1990536
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HLA matching effect: better survival rates and graft quality.
    Cho YW; Cecka JM; Terasaki PI
    Clin Transpl; 1994; ():435-49. PubMed ID: 7547574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A; Gupta N; Siddiqui JA; Margoob A; Bhowmik D; Guleria S; Mehra NK
    Hum Immunol; 2007 May; 68(5):362-7. PubMed ID: 17462503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eighteen-year follow-up of a retrospective study of HLA antibody on kidney graft survival.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):121-3. PubMed ID: 19249493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renal transplant rejection. Transient immunodominance of HLA mismatches.
    Gilks WR; Gore SM; Bradley BA
    Transplantation; 1990 Jul; 50(1):141-6. PubMed ID: 2368134
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A reevaluation of the role of IgM Non-HLA antibodies in cardiac transplantation.
    Smith JD; Hamour IM; Burke MM; Mahesh B; Stanford RE; Haj-Yahia S; Robinson DR; Kaul P; Yacoub MH; Banner NR; Rose ML
    Transplantation; 2009 Mar; 87(6):864-71. PubMed ID: 19300190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal transplantation in highly sensitized patients: five years of the SOS Scheme.
    Klouda PT; Corbin SA; Ray TC; Rogers CA; Bradley BA
    Clin Transpl; 1990; ():69-73. PubMed ID: 2103180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-HLA-A, B, C and DR antibodies in renal transplant recipients.
    Akiyama N; Kusaba R; Osawa N; Inou T; Kawamura A
    Jpn J Exp Med; 1980 Jun; 50(3):205-11. PubMed ID: 7001096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of HLA matching on the outcome of simultaneous pancreas-kidney transplantation.
    Berney T; Malaise J; Morel P; Toso C; Demuylder-Mischler S; Majno P; Bühler LH; Mentha G;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii48-53, ii62. PubMed ID: 15814550
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FcR blocking activity in serum of actively enhanced rat renal allograft recipients due to IgG anti-class II MHC alloantibody.
    Marshall HE; Bolton EM; Gracie JA; Cocker JE; Sandilands GP; Bradley JA
    Immunology; 1990 Mar; 69(3):379-84. PubMed ID: 2312162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
    Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
    Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Importance of HLA-A, -B and -DR matching in presensitized kidney transplant recipients.
    Busson M; Hors J; Prevost P; Raffoux C; Betuel H; Bignon JD; Tongio MM; Seignalet J; Calot M; Lepetit JC
    Clin Transpl; 1988; ():199-202. PubMed ID: 3154473
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.
    House AA; Chang PC; Luke PP; Leckie SH; Howson WT; Ball EJ; Tan AK; Rehman F; Muirhead N; Hollomby DJ; McAlister VC; Hodsman AB; Jevnikar AM
    Transplantation; 2007 Sep; 84(6):722-8. PubMed ID: 17893605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.